Warren L. DeSouza

2016

In 2016, Warren L. DeSouza earned a total compensation of $1.7M as Former Chief Financial Officer at Aimmune Therapeutics, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$116,200
Option Awards$1,270,445
Salary$332,000
Total$1,718,645

DeSouza received $1.3M in option awards, accounting for 74% of the total pay in 2016.

DeSouza also received $116.2K in non-equity incentive plan and $332K in salary.

Rankings

In 2016, Warren L. DeSouza's compensation ranked 5,598th out of 14,075 executives tracked by ExecPay. In other words, DeSouza earned more than 60.2% of executives.

ClassificationRankingPercentile
All
5,598
out of 14,075
60th
Division
Manufacturing
2,021
out of 5,489
63rd
Major group
Chemicals And Allied Products
643
out of 1,895
66th
Industry group
Drugs
484
out of 1,538
69th
Industry
Pharmaceutical Preparations
384
out of 1,176
67th
Source: SEC filing on April 11, 2018.

DeSouza's colleagues

We found three more compensation records of executives who worked with Warren L. DeSouza at Aimmune Therapeutics in 2016.

2016

Jeffrey Knapp

Aimmune Therapeutics

Chief Operating Officer

2016

Stephen Dilly

Aimmune Therapeutics

Chief Executive Officer

2016

Daniel Adelman

Aimmune Therapeutics

Chief Medical Officer

In-depth

You may also like